Cargando…

Right Atrial Phasic Function in Heart Failure with Preserved Ejection Fraction: Cardiac Magnetic Resonance Feature Tracking and Outcomes

Background: This study sought to investigate the prognostic impact of right atrial (RA) size and function in patients with heart failure with preserved ejection fraction (HFpEF) in sinus rhythm (SR) and atrial fibrillation (AF). Methods: Consecutive HFpEF patients were enrolled and indexed RA volume...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schönbauer, Robert, Hana, Fiona, Duca, Franz, Koschutnik, Matthias, Donà, Carolina, Nitsche, Christian, Sponder, Michael, Lenz, Max, Lee, Jonghui, Loewe, Christian, Hengstenberg, Christian, Mascherbauer, Julia, Kammerlander, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455785/ https://www.ncbi.nlm.nih.gov/pubmed/37629221 http://dx.doi.org/10.3390/jcm12165179

Ejemplares similares

Prognostic impact of left atrial function in heart failure with preserved ejection fraction in sinus rhythm vs. persistent atrial fibrillation
por: Schönbauer, Robert, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant
por: Kammerlander, Andreas A., et al.
Publicado: (2021)

Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters
por: Schönbauer, Robert, et al.
Publicado: (2019)

Sex Differences in Left Ventricular Remodeling and Outcomes in Chronic Aortic Regurgitation
por: Kammerlander, Andreas A., et al.
Publicado: (2020)

Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction
por: Dalos, Daniel, et al.
Publicado: (2019)

Gender-specific differences in valvular heart disease
por: Nitsche, Christian, et al.
Publicado: (2020)

Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding
por: Schrutka, Lore, et al.
Publicado: (2019)

Bioimpedance Spectroscopy Reveals Important Association of Fluid Status and T(1) ‐Mapping by Cardiovascular Magnetic Resonance
por: Donà, Carolina, et al.
Publicado: (2022)

Gender-related differences in heart failure with preserved ejection fraction
por: Duca, Franz, et al.
Publicado: (2018)

Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography
por: Bardach, Constanze, et al.
Publicado: (2022)

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial( )
por: Dachs, Theresa Marie, et al.
Publicado: (2022)

Transcatheter treatment by valve-in-valve and valve-in-ring implantation for prosthetic tricuspid valve dysfunction
por: Dannenberg, Varius, et al.
Publicado: (2021)

Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction
por: Mascherbauer, Julia, et al.
Publicado: (2017)

Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance
por: Goliasch, Georg, et al.
Publicado: (2015)

Cerebral Protection in TAVR—Can We Do Without? A Real-World All-Comer Intention-to-Treat Study—Impact on Stroke Rate, Length of Hospital Stay, and Twelve-Month Mortality
por: Donà, Carolina, et al.
Publicado: (2022)

Transcatheter Versus Surgical Valve Repair in Patients with Severe Mitral Regurgitation
por: Koschutnik, Matthias, et al.
Publicado: (2022)

Invasive Hemodynamic Assessment and Procedural Success of Transcatheter Tricuspid Valve Repair—Important Factors for Right Ventricular Remodeling and Outcome
por: Dannenberg, Varius, et al.
Publicado: (2022)

Fluid overload in patients undergoing TAVR: what we can learn from the nephrologists
por: Nitsche, Christian, et al.
Publicado: (2021)

Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction
por: Karakus, Gültekin, et al.
Publicado: (2015)

Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
por: Schrutka, Lore, et al.
Publicado: (2022)

Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging
por: Agibetov, Asan, et al.
Publicado: (2021)

Clinical Impact of Pre-Procedural Percutaneous Coronary Intervention in Low- and Intermediate-Risk Transcatheter Aortic Valve Replacement Recipients
por: Winter, Max-Paul, et al.
Publicado: (2021)

Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome
por: Nitsche, Christian, et al.
Publicado: (2020)

Prevalence and prognostic significance of right ventricular systolic dysfunction in heart failure with preserved ejection fraction. Insights from a cardiac magnetic resonance imaging study
por: Aschauer, Stefan, et al.
Publicado: (2015)

A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation
por: Heitzinger, Gregor, et al.
Publicado: (2023)

The Relationship Between Cardio-Ankle Vascular Index and Left Atrial Phasic Function in Hypertensive Patients With Preserved Ejection Fraction
por: Tabata, Tsuyoshi, et al.
Publicado: (2021)

Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction: Study protocol for a randomized controlled trial
por: Mascherbauer, Julia, et al.
Publicado: (2016)

Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling: Ready for prime time?
por: Kammerlander, Andreas A., et al.
Publicado: (2017)

What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection Fraction
por: Rettl, René, et al.
Publicado: (2020)

A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation
por: Heitzinger, Gregor, et al.
Publicado: (2022)

RANTES and CD40L under Conditions of Long-Term Physical Exercise: A Potential Link to Adaptive Immunity
por: Lenz, Max, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction
por: Rossitto, Giacomo, et al.
Publicado: (2020)

Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future
por: Wintrich, Jan, et al.
Publicado: (2020)

Epicardial fat volume is inversely correlated with the degree of diastolic dysfunction and outcome in patients with heart failure with preserved ejection fraction
por: Karakus, Gültekin, et al.
Publicado: (2013)

Tubulin expression and modification in heart failure with preserved ejection fraction (HFpEF)
por: Schulz, Lisa, et al.
Publicado: (2022)

Diffuse myocardial fibrosis by post-contrast T1-time predicts outcome in heart failure with preserved ejection fraction
por: Marzluf, Beatrice A, et al.
Publicado: (2013)

The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Weerts, Jerremy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b31ep1fb6repm4g9160glphp4p